Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mach7 Technologies ( (AU:M7T) ) has provided an update.
Mach7 Technologies Limited has announced an update on its ongoing share buy-back program, with a total of 5,290,000 ordinary fully paid securities bought back as of June 11, 2025. This strategic move is part of the company’s efforts to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology industry, focusing on providing innovative healthcare solutions. The company is known for its advanced medical imaging and data management software, which aids healthcare providers in improving patient care and operational efficiency.
Average Trading Volume: 245,556
Technical Sentiment Signal: Sell
Current Market Cap: A$84.43M
Find detailed analytics on M7T stock on TipRanks’ Stock Analysis page.